Background. The purpose of this study was to determine (1) the role of emergency cardiopulmonary bypass (CPB) after prolonged cardiac arrest and failed cardiopulmonary resuscitation, and (2) the use of systemic hyperkalemia during CPB to convert intractable ventricular fibrillation (VF).
S uccessful cardiopulmonary resuscitation (CPR) after cardiac arrest (CA) is possible in approximately 20%
to 40%, yet survival is only 5% to 10% and the majority of survivors have permanent brain damage [1] . Conversely, survival rates of up to 50% can be achieved if CPR with early defibrillation is provided within 4 to 5 minutes, but is negligible if these critical time intervals double, with a greater than 95% mortality in victims after prolonged (unwitnessed) CA [2] [3] [4] [5] .
Cardiopulmonary bypass (CPB) expands the time window for successful resuscitation after CA when compared with conventional CPR [6, 7] , as 80% to 100% survival and complete cardiac and neurologic recovery occur after 5 to 10 minutes of CA in dogs [7, 8] . Time is a critical factor, as mortality increases substantially (approximately 80%) and no neurologic recovery occurs after CPR-advanced life support (CPR-ALS) after 12.5 minutes of no-flow CA [9] . This is curtailed with CPB, with a 70% survival and 50% of dogs gaining consciousness after 12.5 minutes of CA. However, after 15 minutes of CA, there is no survival with CPR-ALS and even though CPB allows approximately 25% to 80% survival, it fails to prevent severe neurologic damage [7, 10 -12] . Furthermore, despite the improvements conferred by CPB, intractable ventricular fibrillation (VF) after prolonged CA remains a survival barrier; it occurs in 20% to 50% of animals after CA arrest of 15 minutes, and results in 100% mortality from cardiogenic shock [7, 11, 13] .
Although these findings imply that emergency CPB is superior to CPR-ALS for resuscitation after prolonged CA, none of these studies implemented a preceding CPR interval that is mandatory in the clinical setting for before CPB is initiated. The present study was aimed to assess whether emergency normothermic CPB as a resuscita-tion tool can improve recovery after 15 minutes of CA (simulating an unwitnessed arrest), when CPR-ALS is ineffective. As a secondary objective, we tested the hypothesis that potassium as a depolarizing cardioplegic agent can offset intractable VF after prolonged CA unresponsive to defibrillation, and improve survival of this otherwise lethal cohort.
Material and Methods
The study was approved by the Institutional Animal Research Committee of the University of California at Los Angeles. All animals received humane care in compliance with the 1996 NRC Guide for the Care and Use of Laboratory Animals.
Thirty-one Yorkshire-Duroc pigs (35.2 Ϯ 1.8 kg) were premedicated with 15 mg/kg ketamine and 0.5 mg/kg diazepam intramuscularly. Neuromuscular blockade was achieved by a single pancuronium bolus (0.2 mg/kg). Endotracheal intubation anesthesia was maintained with inhaled isoflurane (1.2% to 1.5%), using a volume-controlled ventilator (Servo 900C, Siemens Elema, Solna, Sweden) at 12 to 14 breaths/min, 10 to 15 mL/kg tidal volume, and adjusted to normalize arterial blood gases.
Heart rate and rhythm were determined by electrocardiography, arterial pressure using a catheter inserted into the left internal thoracic artery, and pulmonary artery pressure by a Swan-Ganz catheter (model 132F5, Baxter Healthcare Corp, Irvine, CA) inserted through the right subclavian vein. Cefazolin (30 mg/kg, GlaxoSmithKline, Philadelphia, PA) was given every 8 hours, and normal saline solution was infused intravenously at 5 to 10 mL · kg Ϫ1 · h Ϫ1 . Body temperature was kept at 37°C using a heating pad. Sterile incisions were performed to expose the right femoral artery and right external jugular vein.
Cardiac Arrest and Resuscitation Protocol
After baseline measurements, systemic heparinization (300 IU/kg) was given before inducing CA. No-flow CA was maintained for 15 minutes without ventilation after inducing VF with a 60-Hz (4.5 A) alternating current (AC-Fibrillator, Medtronic, Inc, Minneapolis, MN) stimulus to the right ventricular endocardium using a catheter (Bard Electrophysiology, Lowell, MA) inserted through the right subclavian vein.
The resuscitation protocol was initiated after 15 minutes of CA by using the American Heart Association advanced cardiac life support algorithm (ALS) (http:// www.americanheart.org) [14] for 10 minutes, yielding 80 to 100 manual chest compressions per minute and bag ventilation at 12 to 15 breaths/min. Defibrillation was attempted after five cycles of CPR, with 200 J (Lifepak 9P, Physio-Control Corp, Redmond, WA), and repeated after every five CPR cycles with 300 to 360 J until spontaneous circulation (ROSC) was restored. Intravenous epinephrine (0.02 to 0.04 mg/kg) was administered 2 minutes after beginning CPR, and repeated every 2 to 5 minutes as needed. Lidocaine (1 mg/kg) was given if a shockable heart rhythm was present, and repeated until reaching the maximal dosage (3 mg/kg). Cardiopulmonary resuscitation intensity was adjusted to achieve a targeted coronary perfusion pressure of greater than 15 mm Hg as indicated by the difference of diastolic arterial pressure and central venous pressure.
Arterial (12F) and venous (19 to 21F) cannulas (Medtronic, Inc) were inserted into the femoral artery and right atrium (through the external jugular vein) and connected to the CPB circuit during the CPR-ALS interval. Extracorporeal circulation consisted of a membrane oxygenator (Affinity NT 541, Medtronic, Inc), an arterial roller pump (Sarns, Ann Arbor, MI), and a venous centrifugal pump (Biopump BPX-80, Medtronic, Inc) for active venous suction. The extracorporeal circuit was primed with 800 mL of Plasma-Lyte (Baxter Healthcare Corp), 700 mL of stored porcine packed donor blood, heparin (100 IU/kg), and calcium chloride to maintain normocalcemia (approximately 1.2 mmol/L).
Restoration of stable circulation (ROSC) during CPR-ALS was defined as return of supraventricular rhythm with the ability to maintain a mean arterial pressure greater than 50 mm Hg for 1 minute. Cardiopulmonary bypass was initiated when 10 minutes of CPR-ALS failed to achieve ROSC, defined as (1) raising mean arterial pressure greater than 50 mm Hg (CPB-Hypo), or (2) persistence of ventricular fibrillation (CPB-VF), which was further subdivided into three cohorts based on the length and treatment of VF: VF Յ 10 min group: Cardioversion was achieved during the first 10 minutes of CPB with countershocks (360 J) repeated every 3 minutes on CPB. VF Ͼ 10 min group: Animals with intractable VF persisting past the initial 10 minutes on CPB were randomized to receive either repeated countershocks every 3 to 5 minutes (VF Ͼ 10 min), or a 15 mEq/L potassium bolus (2 mEq/mL) into the arterial line of the CPB circuit for 10 to 20 seconds (VF Ͼ 10 min ϩ potassium).
Cardiopulmonary Bypass Management and Postoperative Care
Peripheral CPB was established at approximately 300 mm Hg arterial partial pressure of oxygen, and flow was adjusted (100 to 150 mL · kg Ϫ1 · min
Ϫ1
) to maintain an arterial pressure of 50 to 70 mm Hg and a mixed venous oxygen saturation of greater than 70%. Body temperature was kept at 37°C. Arterial blood gases, electrolytes, and hematocrit were measured every 15 to 30 minutes to ensure optimal levels (Blood Gas System 288, Ciba Corning, Midfield, MA), and activated clotting time was kept greater than 400 seconds. Discontinuation of CPB was initiated when there was a stable heart rhythm for 30 minutes, and mean arterial pressure was greater than 50 mm Hg with or without inotropic (dopamine 5 to 10 g · kg Ϫ1 · min
) support. Protamine was given to antagonize systemic heparinization, cannulas were removed, femoral vessels were repaired, and all wounds were closed. Postoperative inotropic support was adjusted to maintain mean arterial pressure between 50 and 70 mm Hg. Animals were extubated when they were able to maintain normal arterial partial pressures of oxygen and carbon dioxide with spontaneous breathing. Animals were monitored for 24 hours after CPB or for an equal period when CPB was not used.
Hemodynamic and Biochemical Determinations
Hemodynamic measurements were made before induction of VF (baseline) and after discontinuation of CPB or at equal time intervals in animals without CPB. Cardiac output was determined by triplicate injections of 4°C cold saline solution, and cardiac index and left ventricular stroke work index were calculated using standard equations.
Arterial blood was sampled at baseline, after CPB, and at 24 hours with samples centrifuged (1,000 ϫ g) for 10 minutes and stored at Ϫ20°C until analysis. To mark cardiac and brain injury, creatine kinase-MB activity was assessed by the ultraviolet-spectrophotometric method (Sigma Chemical Co, St. Louis, MO), and neuron-specific enolase was quantified using an Enzyme Immunometric Assay (SynX Pharma Inc, Toronto, ON) according to the manufacturer's recommendation.
Neurologic Deficit Score and Magnetic Resonance Imaging
Neurologic assessment was performed at 4 and 24 hours after CPB using a species-specific behavior scale, and seizure activity was evaluated [15, 16] . The neurologic deficit score assesses five neurologic components (cranial nerves, motor and sensory, respiration, consciousness, behavior) with a score of 0 to 100 in each category: 0 ϭ normal, 500 ϭ brain death. Neurologic deficit score was independently assessed by 2 laboratory individuals, and the mean value was recorded if scores were different.
After assessment of the 24-hour neurologic deficit score, 4 CPB survivors underwent brain magnetic resonance imaging (MRI) after sedation and endotracheal intubation. Studies were performed on a 3.0-T magnetic resonance system (Magnetom Trio, Siemens Medical Solutions, Malvern, PA), using an axial T 2 -weighted (T 2 W) MRI scan. Tissue hyperintensity on T 2 W turbo spin echocardiography sequence was used to define completed acute infarction when the diffusion scan was positive. Axial diffusion-weighted MRI was performed to identify sites of acute ischemia when the T 2 W sequence was normal, or completed infarction when T 2 W hyperintensity was present. A three-dimensional time of flight magnetic resonance angiogram was used to demonstrate patency of the cerebral vessels, and brain perfusion sequence was obtained using gadodiamide (Omniscan, GE Amersham Health Inc, Princeton, NJ). Scans were evaluated by an experienced neuroradiologist (P.V.).
Statistical Analysis
Data were expressed as mean Ϯ standard error of the mean. Two-way analysis of variance with Fisher's least significant difference procedure for post-hoc repeated measurements was used to analyze intragroup and intergroup differences. Perioperative characteristics of groups were analyzed by Student's t test for continuous data and 2 or Fisher's exact test for categorical data. Probability values less than 0.05 were considered statistically significant.
Results
Baseline hemodynamic and blood gas data were similar in all animals. The VF amplitude was 0.64 Ϯ 0.04 mV immediately after VF induction, and declined to 0.33 Ϯ 0.05 mV (52% of baseline; p Ͻ 0.05) at 7.5 minutes, and was almost abolished at 15 minutes (0.20 Ϯ 0.03 mV; 31% of baseline; p Ͻ 0.05). Cardiopulmonary resuscitation-ALS consistently produced coronary perfusion pressure greater than 15 mm Hg with average coronary perfusion pressure of 29 Ϯ 3, 28 Ϯ 6, and 31 Ϯ 5 mm Hg at 3, 6, and 10 minutes of CPR, respectively. Successful defibrillation was achieved in 11 of 31 animals (35%) during CPR-ALS, but ROSC was possible in only 6 (19%; ROSC group; Fig 1) . Consequently, 81% of animals were subjected to emergency CPB after 10 minutes of CPR-ALS, 5 with persistent hypotension (16%; CPB-Hypo) and 20 with intractable VF (65%; CPB-VF). Seven of 20 (35%) animals with intractable VF were successfully cardioverted during the first 10 minutes of CPB (VF Յ 10 min), whereas 13 of 20 pigs remained in VF more than 10 minutes. Within this cohort, 6 animals underwent repeated defibrillation until successful cardioversion, whereas electromechanical quiescence was quickly achieved in the remaining 7 pigs after delivering potassium (average dose, 14.7 Ϯ 1.7 mEq/L) through the CPB arterial line. Systemic hyperkalemia resulted in a brief interval of asystole (20 to 60 seconds), followed by initial bradycardia, with recovery to a normal heart rate in all but 1 animal that experienced recurrent VF that was defibrillated by one electrical shock.
Total epinephrine dose, number of shocks during CPR-ALS, time until defibrillation, total CPB time, and inotropic support requirements are summarized in Table 1 . Total epinephrine dose and number of defibrillations during CPR were similar in all groups. More total shocks were needed when CPB was initiated for intractable VF and, especially, in the CPB-VF greater than 10 minutes group without potassium, in which 11.1 Ϯ 0.8 countershocks were required during CPB (p Ͻ 0.05), and 1 animal with prolonged VF could not be weaned from CPB owing to cardiac failure. Conversely, all animals in the CPB-Hypo group and 19 of 20 placed on CPB for persistent VF could be weaned from CPB. However, duration on CPB differed in regard to intractable VF management, with earlier CPB discontinuation being possible in VF less than or equal to 10 minutes and VF greater than 10 minutes plus potassium groups.
Hemodynamic and Biochemical Measurements
As shown in Table 2 , resuscitation on CPB increased heart rate and mean pulmonary artery pressure and decreased left ventricular stroke work index (p Ͻ 0.05), but did not change cardiac index or mean arterial blood pressure. However, myocardial failure occurred after prolonged VF (CPB-VF Ͼ 10 min), with reduced mean arterial pressure, cardiac index, and left ventricular stroke work index (p Ͻ 0.05). These adverse hemodynamic consequences were offset by inducing hyperkalemic arrest with potassium, as CPB duration was lowered to 99 Ϯ 9 minutes, fewer shocks (1.8 Ϯ 0.3) were needed compared with the VF greater than 10 minutes group without potassium (Table 1) , and post-CPB hemodynamic recovery was similar to all other groups.
Creatine kinase-MB and neuron-specific enolase levels were elevated in all groups after CA (Table 3) , implying severe myocardial and brain cellular damage. Biochemical markers of cardiac and cerebral injury tended to be higher after prolonged VF (CPB-VF Ͼ 10 min), but differences did not reach statistical significance. In the CPB-VF greater than 10 minutes groups, potassium blood CI ϭ cardiac index; CPB ϭ cardiopulmonary bypass; HR ϭ heart rate; Hypo ϭ hypotension; LVSWI ϭ left ventricular stroke work index;
MAP ϭ mean arterial pressure; MPAP ϭ mean pulmonary artery pressure; PCWP ϭ pulmonary capillary wedge pressure; ROSC ϭ return of spontaneous circulation; VF ϭ ventricular fibrillation.
concentrations (Fig 2) were higher after potassium bolus injection compared with the no treatment group, with levels returning to normal in both groups by the time CPB was discontinued.
Survival
Twenty-four-hour survival was 83% (5 of 6 pigs) after CPR-ALS and 64% (16 of 25 pigs) with CPB (Table 4 ). In the CPB cohort, 100% of animals survived when hypotension was the reason for CPB. In contrast, 24-hour survival was 71% (5 of 7 pigs) if VF was successfully converted within 10 minutes (CPB-VF Յ 10 min), whereas mortality was 100% (6 of 6 pigs) if successful defibrillation was not achieved after 10 minutes (VF Ͼ 10 min). Conversely, 6 of 7 animals survived in the VF greater than 10 minutes plus potassium group, resulting in 86% survival (p ϭ 0.01 versus VF Ͼ 10 min). Cardiogenic shock with severe hypotension was responsible for all deaths.
Neurologic Deficit Score and Magnetic Resonance Imaging
Neurologic deficit score was highest at 4 hours, averaging 220 Ϯ 9 for all survivors (Table 4) , and improved slightly to 197 Ϯ 10 by 24 hours (p Ͻ 0.05), but did not differ among groups. All animals were conscious and breathing spontaneously but none could sit, stand, walk, eat, or drink. Generalized clonic seizures occurred in 71% of survivors. Contrast-enhanced magnetic resonance angiography demonstrated normal, patent cerebral arteries in all animals and no intracranial bleeding, and brain perfusion sequences showed no abnormalities. In the T 1 -weighted sequence the cerebral cortical mantle, brainstem, and cerebellum were normal with no appreciable mass effect or brain swelling. High T 2 W signal intensity was present in the basal ganglia, including the globus pallidus (4 of 4 animals), putamen (4 of 4 animals), and nucleus caudatus (2 of 4 animals), consistent with anoxic or hypoxic brain injury (ie, infarction; Fig 3) . Furthermore, the thalamus, CK-MB ϭ MB fraction of creatine kinase; CPB ϭ cardiopulmonary bypass; Hypo ϭ hypotension; NSE ϭ neuron-specific enolase; ROSC ϭ return of spontaneous circulation; VF ϭ ventricular fibrillation. Hypo ϭ hypotension; NDS ϭ neurologic deficit score; ROSC ϭ return of spontaneous circulation;
Fig 2. Mean potassium plasma concentrations (mEq/L) in animals with or without receiving a potassium bolus after 10 minutes on cardiopulmonary bypass (CPB
VF ϭ ventricular fibrillation.
cerebellum, and portions of the brainstem were affected in 2 of 4 animals, but none exhibited cortical infarction.
Comment
Hemodynamic recovery and survival were markedly improved by using emergency CPB after the otherwise lethal injury of 15 minutes of CA, simulating an unwitnessed CA. Only 19% successful resuscitation occurred after conventional CPR-ALS, whereas CPB (1) augmented post-CA hypotension, and (2) allowed conversion of intractable VF. Consequently, temporary CPB achieved 64% survival in animals that would otherwise have succumbed with CPR-ALS alone. Prompt defibrillation is an important element for recovery, as VF greater than 10 minutes resulted in 100% mortality. Conversely, survival was 71% when cardioversion was successful during the first 10 minutes on CPB, and 86% when systemic potassium was used to gain defibrillation on CPB. Unfortunately, improving cardiac survival did not offset the poor neurologic recovery. Three keynotes to treatment include recognizing the role of CPB to overcome myocardial stunning after prolonged CA with CPR-ALS [4] , using transient hyperkalemia on CBP to convert intractable VF, and insights into improving brain recovery. Studies show that less than 10 minutes of experimental CA followed by normothermic CPB results in almost complete myocardial and neurologic recovery [7, 8] . Conversely, after 15 minutes of CA, negligible (approximately 15%) survival has been reported with CPR-ALS alone [7, 10, 12] , and this finding is consistent with the 19% survival reported in our model. Although CPB allowed 64% survival after unsuccessful CPR-ALS, it failed to prevent impaired neurologic recovery and thus agrees with previous CPB reports [7, 10 -12] . Our model differed from them because 15 minutes of CA was followed by CPR-ALS, a clinically imperative interval to allow the time needed for peripheral cannulation necessary for CPB.
The logic underlying our model of using a period of 15 minutes CA followed by 10 minutes of CPR-ALS relates to (1) the inherent delay in initiating CPR in unwitnessed arrest, or (2) inadequate initial CPR owing to untrained bystanders, as shown in a recent report of 99.4% mortality, if arrival of a trained resuscitation team was delayed greater than 20 minutes [17] . Although minimal delay in CPR may exist in hospitals with trained teams, implementation of CPB requires a 10-to 15-minute period of CPR-ALS to allow for rapid surgical or percutaneous access of femoral vessels [18, 19] . A recent systematic review of 54 trials emphasizes the value of emergency CPB for treatment of CA [6] . Among 675 patients receiving CPB for CA, 72% could be weaned successfully off CPB with a 43% survival to hospital discharge, without reporting neurologic outcomes of survivors [6] . Consistent with this, up to 40% survival of patients has been reported when CPB was established within the first 20 to 30 minutes of CPR-ALS [20, 21] . More importantly, simultaneously correcting the underlying cardiac disease that occurs in greater than 60% of CA patients resulted in an approximately 40% to 80% survival with more than 90% of patients having complete neurologic recovery despite CPR-ALS intervals of longer than 40 minutes [19, 22] .
Cardiopulmonary bypass was also a predictor of mortality in our study, as survival was 83% if animals were subjected to CPB because of persistent hypotension or VF less than 10 minutes. Conversely, 100% mortality from myocardial dysfunction occurred after prolonged VF. The cardiac consequences of prolonged VF include increased myocardial oxygen consumption, depletion of high-energy phosphates, and calcium overload, resulting in myocardial stunning, ischemic contracture, and necrosis [2] . Further- more, CPR and electrical shocks become ineffective with time [4, 23] and repeated defibrillation with higher accumulated energy accentuate myocardial injury that worsens post-CA myocardial function and outcome [24] . The high mortality with intractable VF is consistent with previous reports after prolonged CA, where mortality was also 100% [11, 13] . Conversely, the 71% survival after early cardioversion (VF Ͻ 10 min), or 86% after potassium depolarization, supports the importance of CPB to maintain perfusion pressure and early treatment to promptly return spontaneous rhythm.
Use of potassium to limit the myocardial causes of mortality after CA borrows from cardiac surgery in which a warm blood cardioplegic reperfusate ("hot shot") is delivered during CPB [25] . It is also supported by two clinical studies in witnessed CA patients with prolonged VF unresponsive to CPR-ALS, in which CPB was subsequently followed by corrective cardiac surgery using a controlled, substrate-enriched hyperkalemic cardioplegic reperfusion, resulting in excellent post-CA myocardial recovery and approximately 80% survival [22, 26] . Thus, systemic potassium administration during CPB initiates a novel treatment option for refractory VF after prolonged CA.
Nonetheless, the capacity to restore satisfactory hemodynamics in otherwise fatal intractable VF using CPB and potassium addresses only the myocardial aspect of survival. Outcomes also depend on avoidance of damage to other organs, especially the brain. Clinical neurologic score marginally improved between 4 and 24 hours, with MRI and neuron-specific enolase confirming severe neurologic damage with lesions in the basal ganglia, thalamus, cerebellum, and brainstem. Similar MRI findings are reported clinically after prolonged CA (Ͼ6 min), in which increased diffusion-weighted signal intensity occurred in these same brain regions [27] . Hence, CPB as a resuscitative tool for unwitnessed CA successfully salvages the heart, but fails to limit neurologic injury.
Modifying the potassium levels during CPB may reflect only the first step into adjusting the initial reperfusate delivered by the CPB prime to counteract myocardial, brain, and other organ injury. Subsequent alteration of the pump prime and rapid CPB-assisted cooling to moderate whole-body hypothermia (32°to 34°C), which has been shown clinically to improve neurologic recovery and reduce mortality in post-CA patients [28] , might be the keys to limiting reperfusion organ damage. Our prior studies showed attenuation of brain and whole-body ischemic injury after deep hypothermic circulatory arrest by "controlling" (modifying) the initial CPB reperfusate [15, 16] . Future studies may use this information to avoid brain injury by adjusting the pump prime to make it a controlled reperfusate (whole-body "hot shot") after prolonged CA.
Limitations of this study include the absence of brain histology to confirm the neurologic damage and the lack of serial MRI and neurologic deficit score examinations for 3 to 7 days to determine the ultimate extent of brain injury. Systemic heparinization before CA, as performed in our study, is not comparable to the clinical situation and might have influenced outcomes. However, Pytte and colleagues [29] demonstrated that pre-CA anticoagulation with enoxaparin (1 mg/kg) had no influence on hemodynamics or the return of spontaneous circulation after CPR-ALS after 10 minutes of untreated VF. In addition, much larger pre-CA heparin doses (700 IU/kg) were needed to produce favorable effects on survival and neurologic recovery in dogs subjected to 15 minutes of normothermic VF and CPB [30] . Finally, the alternative use of vasopressin and amiodarone (instead of epinephrine and lidocaine), which is equally recommended by the American Heart Association advanced cardiac life support algorithm, may have further improved the ROSC and post-CA outcomes observed in our model.
In conclusion, emergency CPB expands the time window for circulatory resuscitation with improved survival after prolonged CA of 15 minutes, but fails to limit the whole-body or brain reperfusion injury. Furthermore, the treatment option of systemic hyperkalemia for defibrillation allows successful cardioversion of intractable VF with CPB followed by good myocardial recovery and survival. Future therapeutic strategies need to examine ways to limit the deleterious effects of the reperfusionphenomena on post-CA neurologic injury.
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